NYU Langone Health: Myocardial Infarction trials

The registry lists 13 Myocardial Infarction studies with NYU Langone Health as lead sponsor. 1 are open to participants now and 2 have results posted.

Phase 3 2Phase 4 2No phase 9(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Heart Attack Research Program: Platelet Sub-Study (HARP)RecruitingNCT03022552
• Subclinical Cardiovascular Disease in Psoriatic DiseaseCompletedNCT03228017Phase 4Results posted
• Occluded Artery Trial (OAT)CompletedNCT00004562Phase 3Results posted
• CLEAR SYNERGY Neutrophil SubstudyCompletedNCT03874338
• Mechanistic Effects of Colchicine in Patients With Myocardial InfarctionWithdrawnNCT02995512Phase 4
• Women's Heart Attack Research Program: Stress Ancillary StudyCompletedNCT02914483Not applicable
• Heart Attack Research Program- Imaging StudyActive, not recruitingNCT02905357
• Rehabilitation in the Home Setting for Older Adults In the Early Period After Myocardial InfarctionCompletedNCT02804906Not applicable
• Inflammation in Type 2 Myocardial InfarctionWithdrawnNCT02385487
• Research on Infarction With Open Arteries Using OCT and CMRActive, not recruitingNCT02270359Not applicable
• Female Sex is an Independent Predictor of Death and Bleeding Among Fibrinolytic Treated Patients With AMICompletedNCT00245648Phase 3
• Endogenous Estrogen and Coronary Heart Disease in WomenCompletedNCT00005446
• Intermittent ST Depression and Prognosis After Myocardial InfarctionCompletedNCT00005217